Chinese english Germany Japanese Korea

5,11-Dihydro-2-hydroxyindolo[3,2-b]carbazole-6-carboxaldehyde

5,11-Dihydro-2-hydroxyindolo[3,2-b]carbazole-6-carboxaldehyde Struktur
549548-26-7
CAS-Nr.
549548-26-7
Englisch Name:
5,11-Dihydro-2-hydroxyindolo[3,2-b]carbazole-6-carboxaldehyde
Synonyma:
6-Formyl-8-hydroxyindolo[3,2-b]carbazole;5,11-Dihydro-2-hydroxyindolo[3,2-b]carbazole-6-carboxaldehyde;Indolo[3,2-b]carbazole-6-carboxaldehyde, 5,11-dihydro-2-hydroxy-
CBNumber:
CB52550964
Summenformel:
C19H12N2O2
Molgewicht:
300.31
MOL-Datei:
549548-26-7.mol
Request For Quotation

5,11-Dihydro-2-hydroxyindolo[3,2-b]carbazole-6-carboxaldehyde Eigenschaften

Sicherheit

5,11-Dihydro-2-hydroxyindolo[3,2-b]carbazole-6-carboxaldehyde Chemische Eigenschaften,Einsatz,Produktion Methoden

Verwenden

A hydroxy metabolite of aryl hydrocarbon receptor (AhR) ligand Formylindolocarbazole (FICZ): a photoproduct of Tryptophan (T947200).

5,11-Dihydro-2-hydroxyindolo[3,2-b]carbazole-6-carboxaldehyde Upstream-Materialien And Downstream Produkte

Upstream-Materialien

Downstream Produkte

5,11-Dihydro-2-hydroxyindolo[3,2-b]carbazole-6-carboxaldehyde Anbieter Lieferant Produzent Hersteller Vertrieb Händler.

Global( 9)Lieferanten
Firmenname Telefon E-Mail Land Produktkatalog Edge Rate
J & K SCIENTIFIC LTD. 010-82848833 400-666-7788
 jkinfo@jkchemical.com China 96815 76
Chemsky (shanghai) International Co.,Ltd 021-50135380
shchemsky@sina.com China 15421 60
Shenzhen Polymeri Biochemical Technology Co., Ltd. +86-400-002-6226 13028896684
 sales@rrkchem.com China 56070 58
Energy Chemical 021-58432009 400-005-6266
 marketing@energy-chemical.com China 44941 58
Carbosynth --
 sales@carbosynth.com United Kingdom 6018 58
  • 5,11-Dihydro-2-hydroxyindolo[3,2-b]carbazole-6-carboxaldehyde
  • 6-Formyl-8-hydroxyindolo[3,2-b]carbazole
  • Indolo[3,2-b]carbazole-6-carboxaldehyde, 5,11-dihydro-2-hydroxy-
  • 549548-26-7
  • Aromatics
  • Heterocycles
  • Intermediates & Fine Chemicals
  • Metabolites & Impurities
  • Pharmaceuticals
Copyright 2019 © ChemicalBook. All rights reserved